Pharmaceutical industry news

A self-nanoemulsifying drug delivery system for the treatment of Theileria annulata infections in cattle short tile: treatment of Theileria annulata infections

Medical assistance in dying in Canada: a multidisciplinary Pan-Canadian Delphi study to inform clinical practice guidance documents and plan a research agenda

Exercise and Cardiorespiratory fitness Improvement through supervised TraINinG in patients undergoing surgery for Upper GastroIntestinal cancer (EXCITING-UGI): study protocol for a randomized controlled trial

Clinical utility of ultrasound by general practitioners: a systematic review

The Effect of a Supplement Containing Bergamot and Plant Sterols with or Without a Diet on Dyslipidemia: A Randomized Controlled Trial

What ethnography sees that diagnosis misses: A clinical commentary on borderline personality disorder and ‘structures of care and credibility’

Clinical and Financial Outcomes With Minimally Invasive Excision With Epidermal Autografting and Poly‐Lactic Acid Skin Substitute in Adult Mid‐Deep Dermal Burns

Subcutaneous Allergen Immunotherapy With Thermosensitive Hydrogel and Recombinant Birch Pollen Allergen Variant, a Randomised Controlled Trial

Journal writing for enhancing career adaptability in vocational students: a clinical case study

Multidisciplinary intervention in frail elderly patients with cardiovascular diseases: a multicentre, single-blinded, randomised controlled trial

Neoadjuvant anti-HER2 antibody-drug conjugate SHR-A1811 in Hormone Receptor-positive, HER2-low Breast Cancer: A Phase 2 Clinical Trial (HELEN-015)

Bibliography

Conclusion

Moral Authority, Societal Cleavages, and Barriers to Intervention in Brazil and the US

The Boundaries of Protection

Interventions and Their Audiences

Organizational Capacity, Trusted Networks, and Local Access

Commitment, Capacity, and Parish Response

Introduction

Neuroprotective Potential of Diacerein Against Cerebral Ischemia-Reperfusion Injury in Rats: Association with Modulation of Inflammatory and Hypoxia/Apoptosis-Related Signaling Markers

Spine–hip bone mineral density discordance and fracture risk misclassification: clinical value of multi-site DXA in postmenopausal women

Novel blood biomarkers distinguish active pulmonary tuberculosis from non-pulmonary tuberculosis: a prospective, large scale, clinical trial in Eastern China

Implementation and preliminary clinical application of a robotic thoracic telesurgery program in a middle-income country: a structured pathway from simulation to clinical practice

Ask–Audit–Apply: A Framework for Clinical Reasoning with Artificial Intelligence

Study of Acceptance and Commitment Therapy for Parents in the NICU

A Novel Dominant-negative CARD11 Variant Causes Atopy and Immunodeficiency Syndrome

Post-market individual-report phenotypes after pulsed-field ablation for atrial fibrillation in a food and drug administration database

Early and delayed acute kidney injury after contrast-enhanced CT in critically ill adults: a target trial emulation

Whole-exome sequencing in pediatric drug-resistant epilepsy: diagnostic yield and clinical impact in a resource-limited setting

Letter to the editor regarding “Development and internal validation of a clinical prediction model for deep surgical site infection after open extremity fractures: the BIGB2OSS score”

Reconstructive options for myelomeningocele defects: clinical experience and analysis of complications

Blackwell: An Explainable Anamnesis-Based Multi-agent Framework for Remote Clinical Diagnosis

Black Race Predicts Poor Compliance and Higher Prostate Cancer Risk in a Multinational Repeat Biopsy Cohort: Secondary Analysis From the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Clinical Trial

Long‐Term Oncologic Outcomes of Neoadjuvant Tumor‐Directed Immunotherapy (PROSTVAC) Before Radical Prostatectomy for Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Trial

Shortening Protein Total Residence Time to Improve High‐Cycle Purification Efficiency in Integrated Continuous Biomanufacturing

Small Minds?

NCT07795892: Circulating RNA Markers of Ventricular Arrhythmias in Remotely Monitored Patients With Post-Infarction Heart Failure and Implanted Cardioverter-Defibrillators

Study type: OBSERVATIONAL. Phase: .

NCT07795411: Prospective Multiomic Analysis in Small-Cell Lung Cancer

Study type: OBSERVATIONAL. Phase: .

NCT07794774: A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)

Study type: INTERVENTIONAL. Phase: PHASE3.

NCT07794735: A Study of TAK-664 in People With Primary Immunodeficiency Diseases Who Have Not Yet Been Treated With Immunoglobulins

Study type: INTERVENTIONAL. Phase: PHASE4.

NCT07794657: Brief Training Program for General Practitioners on Malnutrition and Adapted Physical Activity

Study type: INTERVENTIONAL. Phase: NA.

NCT07791251: Efficacy and Safety of Inhaled Peramivir Solution for the Treatment of Adults With Uncomplicated Influenza

Study type: INTERVENTIONAL. Phase: PHASE3.

NCT07789600: Trial Evaluating the Analgesic Efficacy of Magnesium Sulfate as an Adjuvant to Bupivacaine in Local Wound Infiltration for Patients Undergoing Modified Radical Mastectomy (MRM) With Axillary Clearance

Study type: INTERVENTIONAL. Phase: NA.

NCT07789236: Mandala Coloring and Music for Cancer Fear and Screening Anxiety

Study type: INTERVENTIONAL. Phase: NA.

NCT07776691: A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)

Study type: INTERVENTIONAL. Phase: PHASE3.

NCT07485569: Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial

Study type: INTERVENTIONAL. Phase: PHASE1.

NCT07466498: Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial

Study type: INTERVENTIONAL. Phase: PHASE2.

NCT07365241: A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Study type: INTERVENTIONAL. Phase: PHASE3.

NCT07269847: Comparing a Healthy Beef-Centric Diet to a Healthy U.S.-Style Diet on Metabolic Health Outcomes in Pre-Diabetic Adults

Study type: INTERVENTIONAL. Phase: NA.

NCT07172698: Effects of a Multicomponent Protocol With Emphasis on Muscle Power Training on Bradykinesia in Individuals With Parkinson's Disease

Study type: INTERVENTIONAL. Phase: NA.

NCT07061964: Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Study type: INTERVENTIONAL. Phase: PHASE2.

NCT07054190: A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

NCT07053514: Same-Day Antiretroviral Therapy as a Behavioral Design Intervention to Reduce Stigma in Key Affected Populations

Study type: INTERVENTIONAL. Phase: NA.

NCT06800313: Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

NCT06747117: A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)

Study type: OBSERVATIONAL. Phase: .

NCT06701903: Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

Study type: INTERVENTIONAL. Phase: PHASE2.

NCT06664619: A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

Study type: INTERVENTIONAL. Phase: PHASE3.

NCT06664034: Intervening on Women's Health for Rural Young Cancer Survivors

Study type: INTERVENTIONAL. Phase: NA.

NCT06470828: A Study of TAK-861 for the Treatment of Narcolepsy Type 1

Study type: INTERVENTIONAL. Phase: PHASE3.

NCT06398418: R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.